[Frontiers in Bioscience 3, e230-237, November 1, 1998]

Table of Conents
 Previous Section   Next Section


A. Scott Pearson, Michael Bouvet, Douglas B. Evans, and Jack A. Roth

Departments of Surgical Oncology (ASP, MB, DBE) and Thoracic and Cardiovascular Surgery (JAR), The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Received 6/25/98 Accepted 7/7/98


1. Abstract
2. Introduction
3. Molecular Biologic Targets in Pancreatic Cancer
3.1. p53
3.2. K-ras
3.3. DPC-4, p16, and Rb
3.4. Bcl-2
3.5. Others
4. Methods for Gene Transfer
4.1. Viruses
4.1.1. Retroviruses
4.1.2. Adenoviruses
4.1.3. Adeno-associated viruses
4.2. Liposomes
4.3. Naked DNA technology
5. Manipulation of Genetic Targets
5.1. Restoration of Tumor Suppressor Genes and Anti-Oncogene Strategies
5.1.1. Gene Overexpression
5.1.2. Antisense, Ribozymes, and Drug Susceptibility Genes
5.2. Immunotherapy
5.3. Bystander Effect
6. Measuring Response to Gene Therapy
6.1. Gene Expression
6.2. Apoptosis and Cell cycle Arrest
7. Current Status of Pre-clinical Gene Therapy Studies in Pancreatic Cancer
8. Perspective
9. Acknowledgments
10. References
11. Entire Manuscript

Key Words: Gene Therapy, Pancreatic Cancer, p53, K-ras, adenovirus Search OMIM (Online Mendelian Inheritance in Man) to find related articles
This form requires a WWW Client such as Netscape, XMosaic, Lynx that supports fill-in forms.

Enter one or more search keywords:

To Search all fields, leave the following boxes unchecked. To narrow your search to certain specific fields, check the boxes next to those fields' names. SeeQuery Help for other ways to search. Title: OMIM Number: Allelic Variants: Text: References: Clinical Synopsis: Gene Map Disorder: Contributors: See only records which have been changed in the past Display at most